FMR CORP 13D/13G Filings for Evelo Biosciences, Inc. (EVLO)

FMR CORP 13D and 13G filings for Evelo Biosciences, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		 Transaction
Date		 Type Company
Symbol		 Filed By
Symbol		 Shares Owned
% Owned		 Shares Vs. Prev Report View
2023-12-11
09:09 am
Sale		 2023-12-08 13G Evelo Biosciences, Inc.
EVLO		 FMR CORP 0
0.000%		 -1,326,267decrease
(Position Closed)		 Filing
2023-11-13
09:02 am
Sale		 2023-11-10 13G Evelo Biosciences, Inc.
EVLO		 FMR CORP 1,326,267
7.041%		 -1,125,985decrease
(-45.92%)		 Filing
2023-08-10
08:19 am
Purchase		 2023-08-09 13G Evelo Biosciences, Inc.
EVLO		 FMR CORP 2,452,252
14.750%		 2,325,827increase
(+1839.69%)		 Filing
2023-07-10
10:20 am
Purchase		 2023-07-07 13G Evelo Biosciences, Inc.
EVLO		 FMR CORP 126,425
2.257%		 126,425increase
(New Position)		 Filing